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Insulin resistance, which implies impairment of insulin
signaling in the target tissues, is a common cause of type 2
diabetes. Adipose tissue plays an important role in insulin
resistance through the dysregulated production and secretion
of adipose-derived proteins, including tumor necrosis factor- , α
plasminogen activator inhibitor-1, leptin, resistin, angioten-
sinogen, and adiponectin. Adiponectin was estimated to be a
protective adipocytokine against atherosclerosis, and also to
have an anti-inflammatory effect. In this study, the relationship
between fasting plasma adiponectin concentration and adi-
posity, body composition, insulin sensitivity (ITT, HOMAIR,
QUICK), lipid profile, fasting insulin concentration were
examined in Korean type 2 diabetes. The difference in the
adiponectin concentrations was also examined in diabetic and
non-diabetic subjects, with adjustment for gender, age and
body mass index. 102 type 2 diabetics and 50 controls were
examined. After a 12-h overnight fast, all subjects underwent
a 75gram oral glucose tolerance test. Baseline blood samples
were drawn for the determinations of fasting plasma glucose,
insulin, adiponectin, total cholesterol, triglyceride, LDL-cho-
lesterol, and HDL-cholesterol. The body composition was
estimated using a bioelectric impedance analyzer (Inbody 2.0).
The insulin sensitivity was estimated using the insulin toler-
ance test (ITT), HOMAIR and QUICK methods. In the diabe-
tic group, the fasting adiponectin concentrations were signifi-
cantly lower in men than in women. They were negatively
correlated with BMI (r=-0.453), hip circumference (r=-0.341),
fasting glucose concentrations (r=-0.277) and HOMAIR (r=
-0.233). In addition, they were positively correlated with
systolic blood pressure (r=0.321) and HDL-cholesterol (r=
0.291). The systolic blood pressure and HDL-cholesterol were
found to be independent variables, from a multiple logistic
regression analysis, which influenced the adiponectin con-
centration. Compared with the non-diabetic group, the adi-
ponectin concentrations were significantly lower in the diabetic
group, with the exception of obese males. In conclusion, the
plasma adiponectin concentrations were closely related to the
insulin resistance parameters in Korean type 2 diabetic
patients.
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INTRODUCTION
Insulin resistance, which implies impairment of
insulin signaling in the target tissues, is a common
cause of type 2 diabetes. Adipose tissue plays an
important role in insulin resistance through the
secretion of adipose-derived proteins, including
tumor necrosis factor-α (TNF-α), plasminogen
activator inhibitor-1, leptin, resistin, angiotensino-
gen and adiponectin.
1,2 Adiponectin was known
as ACRP30, apM1, AdipoQ and GBP28. Recently,
the plasma adiponectin levels were implicated in
obesity and insulin resistance.
3-6 The plasma adi-
ponectin concentrations were inversely correlated
with fasting glucose, fasting insulin concentra-
tions, triglyceride, and body mass index, but posi-
tively correlated with HDL-cholesterol.
7,8
The role of adiponectin has been considered to
have anti-inflammatory and anti-atherogenic
effects. It accumulates in injured vessel walls, and
dose-dependently inhibits the TNF-α signaling
pathway in human aortic endothelial cells and
reduces the TNF-α production in macrophages.
5,9
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The plasma adiponectin concentrations were de-
creased in obese and type 2 diabetic subjects and
closely related to cerebro-vascular disease.
6,7 In
this study, our intension was to observe the dif-
ference in the plasma adiponectin levels in dia-
betic and non-diabetic subjects, with adjustment
for gender, age and body mass index. The rela-
tionship between fasting plasma adiponectin con-
centrations and insulin resistance parameters were
also examined.
MATERIALS AND METHODS
Subjects
The subjects of this study were 102 type 2 dia-
betic and 50 control subjects with normoglycemic
conditions. All subjects were ambulatory patients
seen at the Won-ju Christian Hospital between
October 2002 and January 2003. Diabetes was de-
fined according to the diagnostic criteria recom-
mended by ADA in 1997.
Anthropometric and biochemical measurement
All the subjects' heights, weights, and waist and
hip circumferences were recorded, and their adi-
posity checked by a bioelectrical method (Inbody
2.0, Biospace ). The body mass index (BMI) was
defined as weight (kg)/height (m
2).
A dietitian asked about their daily protein, car-
bohydrate and fat intakes using a Food Ques-
tionnaire. All subjects had their blood pressure
measured. No subjects was using any antihyper-
tensive, antihyperglycemic, or lipid-lowing drugs
before the study evaluation. After 10 hours, all
subjects were given a 75g oral glucose tolerance
test (OGTT). The plasma insulin levels were
measured with a radioimmunoassay kit (Linco
Research Inc., Missouri, USA) and the plasma
adiponectin levels an enzyme-linked immunosor-
bent assay by human adiponectin ELISA kit (B-
Bridge International, Inc., San Jose, CA, USA). The
intra and inter assay coefficients of variation for
adiponectin were 4.6 and 3.2% respectively. The
total cholesterol, HDL-cholesterol, LDL-choleste-
rol and triglyceride were checked after 10 hours
fasting.
Insulin resistance measurement
The insulin resistance was measured by the in-
sulin tolerance test (ITT), HOMAIR (Homeostasis
model assessment) and QUICK (Quantitative in-
sulin sensitivity check).
Insulin tolerance test
After 12 hours fasting, all subjects were admin-
istrated a bolus of Humulin R 0.1 units per kilo-
gram into an antecubital vein, with blood sampled
from a vein on the dorsum of the same hand. To
arterialize the venous blood, the hand was placed
in a water bath held at a constant temperature of
43 for 20 min prior to the start of the infusion
and kept there until the end of the study.
Sampling was carried out 0, 3, 6, 9, 12, and 15
minute after the insulin injection. After 15 minutes
of sampling, the test was terminated by injection
of glucose (20% D/W). Blood samples were
analyzed for whole blood glucose using a Yellow
Springs analyzer (YSI, Yellow Springs, OH, USA).
Linear regression was used to estimate the slope
of the decline in the log transformed blood
glucose concentration. The slope was multiplied
by -100 to derive the glucose disposal rate (Kitt).
The Kitt was equivalent to the percentage decline
in blood glucose per min, as calculated by the for-
mula: 69.3/t1/2. Where t1/2 was the time taken for
the blood glucose to fall from a certain value at
3 minutes to half that value Kitt(%/min)=0.693t1/
2 × 100 . HOMAIR was applied to estimate the de-
gree of insulin resistance HOMAIR=Insulin/
22.5e
-In(glucose) . QUICK
10 was applied to estimate
the degree of insulin resistance 1/log(fasting
insulin) + log(fasting glucose) , where the insulin
and glucose were expressed in U/mL and μ
mmol/L, respectively.
Statistical analysis
All data were expressed as the mean ± SD. The
SPSS 10.0 (Chicago, USA) programs were used for
the statistical analyses. Differences in the means of
the plasma adiponectin between the male and
female groups were tested by the Mann-Whitney
U test. Correlations of the adiponectin and meta-
bolic parameters were calculated by Pearson's
correlation method. Multiple linear regressionMi-Jin Kim, et al. 44
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analyses were used to identify independent deter-
minants of adiponectin. A significant level of 5%
was chosen for all the tests (p value < 0.05).
RESULTS
Clinical data and basic laboratory parameters in
diabetes
The height, weight, total body fat percent, fat
mass, lean mass, waist circumference, and waist to
hip ratio measurements and plasma adiponectin
levels were significantly different between the
male and female groups (Table 1).
Insulin resistance parameters in diabetes
There were no differences in the insulin toler-
ance test, HOMAIR, and QUICK between the
male and female groups (Table 2).
Daily protein, carbohydrate and fat intake in
diabetes
The daily protein, carbohydrate and fat intakes
Table 1. Clinical and Biochemical Characteristics in Diabetic Patients
Total Male Female
Number 102 61 41
Age (year) 53.4 ± 12.1 51.3 ± 13.1 56.4 ± 9.8
Height (cm) 160.9 ± 10.3 160.7 ± 7.9 152.3 ± 7.3
Weight (kg) 66.3 ± 11.9 69.5 ± 10.2 61.6 ± 12.9
BMI (kg/m
2) 25.6 ± 3.5 25.1 ± 2.9 26.3 ± 4.2
Total body fat (%) 29.2 ± 7.9 26.0 ± 6.0 33.9 ± 8.1
Fat mass (kg) 20.4 ± 7.2 19.0 ± 7.1 22.4 ± 6.9*
Lean mass (kg) 44.9 ± 10.8 49.1 ± 10.7 38.7 ± 7.7
Waist (cm) 88.4 ± 8.4 86.8 ± 7.9 91.2 ± 8.6*
Hip (cm) 94.5 ± 7.3 94.0 ± 7.3 94.7 ± 7.3
Waist to hip ratio 0.93 ± 0.09 0.92 ± 0.08 0.97 ± 0.07*
Systolic BP (mmHg) 137.1 ± 20.5 135.8 ± 20.6 139.1 ± 20.4
Diastolic BP (mmHg) 81.7 ± 13.6 80.7 ± 13.2 83.0 ± 4.1
Fasting plasma glucose (mol/L) 11.1 ± 4.0 11.2 ± 4.6 10.3 ± 3.6
Fasting plasma insulin (mU/L) 6.7 ± 5.1 6.4 ± 5.2 7.1 ± 5.0
Adiponectin (μg/mL) 5.0 ± 3.7 4.5 ± 3.9 5.9 ± 3.2
Total cholesterol (mmol/L) 5.3 ± 1.2 5.3 ± 1.0 5.4 ± 1.4
HDL-cholesterol (mmol/L) 1.1 ± 0.3 1.1 ± 0.4 1.2 ± 0.3
LDL-cholesterol (mmol/L) 3.9 ± 1.3 4.0 ± 1.1 3.7 ± 1.4
Triglyceride (mmol/L) 4.9 ± 2.2 4.9 ± 2.9 4.7 ± 3.1
HbA1c (%) 9.8 ± 2.4 10.2 ± 2.3 9.3 ± 2.5
Data express mean ± SD.
BMI, Body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
*p<0.05 between male and female groups.
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in the diabetics were 14.5 ± 2.8, 66.6 ± 8.5 and
19.4 ± 7.8%, respectively (Table 3). Diabetic pa-
tients ate more carbohydrate than recommended
by the ‘Korea Diabetes Diet Guideline’: 15 - 20%
protein, 55 - 60% carbohydrate, and 20 - 25% fat.
11
There was no intake difference between the male
and female groups, regardless of obesity (Table 4).
The daily protein intake was significantly cor-
related with HOMAIR (r=0.370, p < 0.001) and
QUICK (r=-0.289, p< 0.05). Neither the daily carbo-
hydrate nor fat intakes were significantly corre-
lated with the Kitt, HOMAIR or QUICK, nor the
daily protein, carbohydrate and fat intakes with
the plasma adiponectin concentration.
Insulin resistance parameters and adiponectin
The Kitt value was highly correlated with the
hemoglobin A1c (r=-0.404, p < 0.001), and corre-
lated with the fasting glucose, hip circumference,
and HDL-cholesterol. HOMAIR was highly cor-
related with QUICK (r=-0.594, p < 0.001), and cor-
related with the lean mass, daily protein intake,
weight, height, age, plasma adiponectin concen-
tration, body mass index and fat mass. QUICK
was highly correlated with HOMAIR (r=-0.594,
p<0.001), fat mass (r=-0.447, p<0.001), and waist
circumference (r=-0.429, p<0.001), and correlated
with the body mass index, weight, hip circum-
ference, daily protein intake, hemoglobin A1c, and
lean mass.
Correlation of adiponectin and metabolic
parameters in type 2 diabetes
The plasma adiponectin concentration was
negatively correlated with the body mass index
(r=-0.453, p<0.001), hip circumference (r=-0.341,
p<0.001), fasting glucose (r=-0.277, p<0.001) and
HOMAIR (r=-0.233, p<0.05), and positively corre-
lated with the systolic blood pressure (r=0.321,
p<0.001) and HDL-cholesterol (r=0.291, p<0.001).
In the multiple logistic regression analysis, the
systolic blood pressure and HDL-cholesterol were
Table 2. Insulin Resistance Parameters in Type 2 Diabetes
Total Male Female
Kitt 2.17 ± 1.2 2.20 ± 1.2 2.14 ± 1.3
HOMAIR 3.26 ± 3.1 3.70 ± 3.6 2.72 ± 2.1
QUICKI 0.63 ± 0.3 0.63 ± 0.3 0.65 ± 0.2
Table 3. Daily Protein, Carbohydrate, and Fat Intakes of the Type 2 Diabetics
Total Male Female
Protein (%) 14.5 ± 2.8 13.9 ± 2.7 15.0 ± 2.7*
Carbohydrate (%) 66.6 ± 8.5 66.8 ± 8.5 66.1 ± 8.7
Fat (%) 19.4 ± 7.8 19.8 ± 8.3 19.0 ± 7.1
*p<0.05 between male and female groups.
Table 4. Daily Protein, Carbohydrate and Fat Intakes of the Type 2 Diabetics in Relation to Obesity
Male Female
BMI < 25kg/m
3 BMI 25kg/m
3 BMI < 25kg/m
3 BMI 25kg/m
3
Protein (%) 14.1 ± 3.2 14.0 ± 2.6 14.7 ± 2.2 15.9 ± 2.6
Carbohydrate (%) 65.0 ± 9.1 66.2 ± 7.9 66.9 ± 6.0 64.9 ± 10.3
Fat (%) 21.0 ± 6.4 21.1 ± 10.0 18.6 ± 5.0 19.1 ± 8.5Mi-Jin Kim, et al. 46
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significant independent variables for the plasma
adiponectin concentration (Table 5).
Plasma adiponectin concentrations according to
obesity
The plasma adiponectin concentration was sig-
nificantly lowered in the diabetic group compared
to the non diabetic group, with the exception for
obese males, after adjustment for age, gender and
BMI (Fig. 1).
DISCUSSION
Obesity is commonly associated with insulin
resistance and hyperinsulinemia, and is a major
risk factor in the development of type 2 diabetes
and cardiovascular disease. Free fatty acids, de-
rived from adipose tissue, have long been impli-
cated in the development of these obesity-related
complications.
12 TNF-α, which is also derived from
adipose tissue, has direct effects on the insulin
signaling cascade, and inhibits GLUT4 gene
expression.
1,2,12,13 Plasminogen activator inhibitor
type
1,11,14 interleukin 6
15 and complement 3
16 cause
insulin resistance and diabetes related cardio-vas-
cular complications.
Adiponectin is a 244-amino acid protein, with
high structural homologies to collagen VIII, X and
complement C1q
17-20 as well as TNF-α.
21 Although
the physiological role of adiponectin remains to be
fully determined, this protein accumulates in in-
jured vessel walls, and dose-dependently inhibits
TNF- induced cell adhesion in human aortic α
endothelial cells.
5,8 Furthermore, adiponectin has
recently been reported to have an inhibitory effect
on the proliferation of myelomonocytic progeni-
tors, as well as on the phagocytic activity and
TNF-α production by macrophage.
22
The plasma adiponectin levels were decreased
in obese Caucasians
23 and Japanese
6,7 with type 2
diabetes. Recently, an intra venous injection of the
c-terminus globular domain of the mouse homo-
logue of adiponectin was demonstrated to reduce
the plasma fatty acid levels and diet induced
weight gain in mice.
24 This indicated that adipo-
nectin may participate in fatty acid metabolism
Table 5. Multiple Linear Regression Analysis for the Fasting Adiponectin Concentration, and the Anthropometric,
and Metabolic Parameters in the Diabetics
Independent variable Standardized coefficient(Beta) t
Sex 0.311 1.582
Age 0.064 0.336
Weight 0.121 0.279
BMI -0.244 -0.851
Lean mass -0.111 -0.488
Waist 0.007 0.037
Hip -0.013 -0.062
Systolic BP 0.297 2.081*
Fasting glucose 0.015 0.122
HDL-cholesterol 0.450 3.299*
HOMAIR -0.127 -0.892
R
2 0.548
F 3.526*
Dependent variables: Fasting adiponectin concentration.
*p < 0.05.Plasma Adiponectin and Insulin Resistance in Korean Type 2 Diabetes Mellitus 47
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and energy homeostasis.
24 Treatment of adiponec-
tin increased muscle free fatty acid β-oxidation
and decreased gluconeogenesis in the liver.
9,24,25
The plasma adiponectin level was found to be
lower in obese human subjects.
9,19,26 In ob/ob
mice, the steady state mRNA of adipoQ was also
found to be down regulated.
19 The expression of
adiponectin is considered to be activated during
adipogenesis, but a feedback inhibition of its pro-
duction may be imposed in the development of
obesity. Yang et al.
26 reported a change in the
plasma adiponectin levels with body weight
reduction among 22 obese patients who received
gastric portion surgery. A 46 percents increase in
the mean plasma adiponectin levels was accom-
panied by a 21% reduction in the mean body mass
index. As a result, the plasma triglyceride was
significantly decreased and the insulin resistance
recovered. They insisted that weight reduction of
obese patients increased the adiponectin levels
and has a protective effect against cardio-vascular
disease and diabetes related complications.
Nishizawa et al.
27 indicated that androgens de-
creased the plasma adiponectin level and that
androgen-induced hypoadiponectinemia may be
related to a high risk of insulin resistance and
atherosclerosis in men. In our study, the plasma
adiponectin concentration was observed to be
lowered further in men than in women (4.5 ± 3.9
vs. 5.9 ± 3.2μ/mL). Hypoadiponectinemia in men
is thought to be partially responsible for the effect
of androgen. However, the total body fat may
affect the plasma adiponectin levels. So there is a
need to carefully interpret only the androgen
effects on hypoadiponectinemia in men.
DeFranzo et al.
28 reported that the hyperinsu-
linemic euglycemic clamp technique is currently
regarded as the gold standard for measuring
insulin sensitivity. However, this method requires
a proficient technique and highly trained per-
sonnel. The insulin tolerance test (ITT) is a well
known technique for measuring insulin resis-
tance.
29-31 Park et al.
32 reported highly significant
correlations between the Kitt value, which is
Fig. 1. Adiponectin concentration difference between diabetic and non-diabetic patients, with adjustment for age, gender
and BMI.Mi-Jin Kim, et al. 48
Yonsei Med J Vol. 46, No. 1, 2005
derived from the ITT and the M (kg/kg/min) or
M/I (mg/kg/min/μU/mL × 100) derived from the
hyperglycemic euglycemic clamp test. QUICK is
also known as a reliable index of insulin sensi-
tivity.
10
In our study, neither Kitt, HOMAIR, nor QUICK
was significantly different between males and
females. For the purpose of data accuracy, Kitt
must be checked repeatedly. However, the Kitt
value was not repeated checked in this study,
which is a possible limitation of the data accuracy.
Our study showed that the hemoglobin A1c
was correlated with Kitt, and inversely correlated
with the fasting insulin concentrations, but not
significantly. The body mass index, fat amount,
and waist circumference were significantly corre-
lated HOMAIR and QUICK, which were same
results previously reported by Laaksonen.
33 Kitt
was significantly correlated with fasting glucose
and hemoglobin A1c; therefore, the fasting glu-
cose and glucose control status were considered
good parameters for insulin resistance measure-
ments in this study.
Neither the daily protein, carbohydrate nor fat
intakes was correlated with the plasma adiponec-
tin concentrations. However, these intakes were
affected by age, gender, diet habit and seasonal
variation, so there is a limit to the interpretation.
Separate studies found the adiponectin concentra-
tion in the plasma correlated negatively with the
fasting insulin levels in Caucasian,
34 Pima Indian
34
and Japanese.
7 In addition, the plasma adiponectin
levels was negatively correlated with the plasma
triglyceride concentration as well as the fasting
and postprandial plasma glucose concentration.
Christian et al.
3 also reported that hypoadiponec-
tinemia was correlated with hyperinsulinemia and
insulin resistance. Berg et al.
25 showed that treat-
ment of thiazolidinedione, a PPARγ agonist, to
db/db mice increased the plasma adiponectin
concentration and improved insulin resistance. In
our study, the plasma adiponectin concentration
was negatively correlated with the body mass
index, hip circumference, fasting glucose and
HOMAIR, but was not significantly correlated with
abdominal obesity, has represented by the waist
circumference. Park et al.
35 reported that the
serum adiponectin levels was inversely correlated
with the subcutaneous adipose tissue area (SAT),
visceral adipose tissue area (VAT), and waist to
hip ratio (WHR). This study agrees with the result
published by Yatagai et al.,
36 which showed that
hypoadiponectinemia was associated with visceral
fat accumulation. It seems likely that the discrep-
ancies among this and several other studies may
have resulted from the different degrees of obesity
of subjects, as well as the difference in gender,
degree of hyperglycemia, and duration of dia-
betes. Additional studies are necessary to eluci-
date the association the adiponectin concentration
with the abdominal obesity determined by com-
puted tomography.
The plasma adiponectin level was positively
correlated with the HDL-cholesterol and systolic
blood pressure. In multiple regression analyses,
the systolic blood pressure and HDL-cholesterol
were significant independent variables for adipo-
nectin. The correlations between adiponectin and
blood pressure was different from those of other
studies. Hypoadiponectinemia has been reported
in essential hypertensive patients.
37 However,
Mallamari et al.
38 reported that hypertensive men
had significantly higher plasma adiponectin levels
than normotensive men. They explained that the
hyperadiponectinemia in hypertensive men was
likely due to the expression of high levels of es-
sential hypertensives as a counter-regulatory re-
sponse aimed at mitigating the endothelial dam-
age and cardiovascular risk associated with high
arterial pressure. The plasma adiponectin levels
may be affected by arterial pressure, but may also
be affected by total body fat, hormones and so on.
Adiponectin, derived from adipose tissue, was
inversely correlated with the amount of body fat.
3,
19,23 Furthermore, the adiponectin level was cor-
related with leptin resistance.
9 Both hyperlepti-
nemia and leptin resistance inhibit adiponectin
synthesis in the adipose tissue.
9 Miyao et al.
39
found an inversely correlation between the plas-
ma adiponectin and leptin concentrations in both
normal weight and obese women. The correlation
between adiponectin and leptin was also reported
by a recent genomic scan study, which revealed
a linkage of the metabolic syndrome to both a
region on chromosome 3q27, where the gene
encoding adiponectin is located, and to regions on
chromosome 17q12 that are strongly linked to the
plasma leptin concentration.
20Plasma Adiponectin and Insulin Resistance in Korean Type 2 Diabetes Mellitus 49
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In this study, the adiponectin concentrations, in
relation to the glucose levels, was lower in the
diabetic than non-diabetic subjects, with the ex-
ception of obese males. Some of the obese male
group with a high body mass index had only a
little amount of fat. To obtain exact data, the total
body fat as well as body mass index must be
adjusted in future studies.
In conclusion, the plasma adiponectin concen-
tration was closely related to the insulin resistance
parameters in Korean type 2 diabetic patients, but
further study will be needed to clarify the rela-
tionship between the adiponectin level and dia-
betes related complications.
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